Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I
about
Immunosuppression Drug Therapy in Lung Transplantation for Cystic Fibrosis.Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part IP70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus.Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.Pilot study of a pharmaceutical care intervention in an outpatient lung transplant clinic.Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBD.Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood.Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study.Evaluation of the immune function assay in pediatric living donor liver transplantation.Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.Individualizing immunosuppression in lung transplantation.Optimal sampling time-point for cyclosporin A concentration monitoring in heart transplant recipients
P2860
Q30234349-8A24E21D-37F9-4F22-9BDF-EBB57C05F2B0Q36183911-1A7F5DFE-8912-4712-B55B-610BAFE8C5A9Q36777485-BFACAEA6-88EC-4B3F-BEE1-321523DC46EDQ36777599-FE86D084-4439-4084-B7F9-7FE93DF1B67BQ36807172-CC1441EC-F094-44D4-926E-8CBF67A18DC2Q37009025-51E2E93A-0E5B-4554-A084-D72BC739A3B2Q38002977-A89A819A-54EA-4D6F-924D-0E207EC0AA84Q39278646-ED6A4083-A370-4699-BCF0-DBF050C78886Q39668342-A13DF41F-B713-41B1-8778-F4BB0A786CF7Q41410382-00020790-194C-4716-94F5-D70B29F55A0FQ41651403-BA295357-08DF-4420-992C-DAB1377860D0Q45188607-6399CA96-3DF9-4307-A6DF-B06820D3154EQ51422263-64672C55-7456-4580-AF89-080EA538DCDAQ55385759-D79F1BB2-698C-43B2-94DF-980D8CC7F970Q58552338-C36DAE36-5520-4519-A499-E76A5439CD0B
P2860
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Pharmacokinetic optimization o ...... oracic transplantation: part I
@ast
Pharmacokinetic optimization o ...... oracic transplantation: part I
@en
Pharmacokinetic optimization o ...... oracic transplantation: part I
@nl
type
label
Pharmacokinetic optimization o ...... oracic transplantation: part I
@ast
Pharmacokinetic optimization o ...... oracic transplantation: part I
@en
Pharmacokinetic optimization o ...... oracic transplantation: part I
@nl
prefLabel
Pharmacokinetic optimization o ...... oracic transplantation: part I
@ast
Pharmacokinetic optimization o ...... oracic transplantation: part I
@en
Pharmacokinetic optimization o ...... oracic transplantation: part I
@nl
P2860
P1476
Pharmacokinetic optimization o ...... oracic transplantation: part I
@en
P2093
Caroline Monchaud
P2860
P304
P356
10.2165/11317230-000000000-00000
P577
2009-01-01T00:00:00Z
P5875
P6179
1002929306